life sciences

14 Jan

Sortis Posted in Media Няма коментари

SORTIS Invest Advised Lexham Capital Partners On The Successful GBP 18.65 Million Fundraising For Lexham Special Opportunities I LP

SORTIS Invest advised Lexham Capital Partners, a London-based secondaries fund manager, on the successful GBP 18.65 million (EUR 21.5 million) fundraising for Lexham Special Opportunities I LP, which was completed on 28 August 2025. As part of the transaction, SORTIS Invest introduced and secured participation from Bulgarian investors. Lexham Special Opportunities I LP is a […]

>>

26 Jan

Sortis Posted in News Няма коментари

SORTIS Invest Advised KDTB Research on the Fundraising for a New Antibiotic for Tuberculosis

KDTB Research, a drug development start-up developing a new medicine for treatment of Tuberculosis, closed a successful funding round with the assistance of SORTIS Invest. The financing was led by Innovation Capital – a venture capital fund located in Sofia, Bulgaria. KDTB Research is a company that specializes in developing superior drugs for treatment of […]

>>

13 Sep

Sortis Posted in News Няма коментари

The Quality Group Continues its Expansion with the Acquisition of GOT7 Nutrition

The Quality Group (“TQG”) has signed an agreement to acquire GOT7 Nutrition GmbH & Co. (“GOT7”). This is yet another acquisition for “The Quality Group”, which is currently in an active expansion period, and has been looking for strategic growth in the food supplements space through M&A. Carlsquare has been the exclusive advisor of TQG […]

>>